Recession concerns sent the markets tumbling during the midday with the Dow collapsing 286 points to 16,162. Nasdaq plunged 95 points to 4,524.
On the upside
VBL Therapeutics (Nasdaq: VBLT) will provide a corporate overview and business update at the 18th Annual BIO CEO & Investor Conference on February 9, 2016.
CalAmp (Nasdaq: CAMP) offered a premium of approximately $134 million in cash to acquire LoJack (Nasdaq: LOJN).
The Female Health Co. (Nasdaq: FHCO) reported higher first quarter earnings and revenue.
On the downside
Waddell & Reed Financial (NYSE: WDR) disappointed with lower fourth quarter earnings and revenue.
Carbylan Therapeutics (Nasdaq: CBYL) reported disappointing results from a Phase III trial of Hydros-TA to treat osteoarthritis pain in the knee.
ADT (NYSE: ADT) reported lower first quarter earnings.
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 1 on the NYSE and by more than 4 to 1 on Nasdaq. The broader S&P 500 plummeted 34 points to 1,905. Bitcoin added $2 to $376.